Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases

Re-irradiation SBRT achieved substantial pain relief with acceptable toxicity, warranting larger randomized trials against conventional radiotherapy.

Authors

Institutions

Publication Details

Journal
Japanese Journal of Clinical Oncology
Published
2025-12-23
DOI
https://doi.org/10.1093/jjco/hyaf215
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases

Hiroaki Ogawa, Y. Nakajima, Kentaro Taguchi, Yuhi Suda et al.
Japanese Journal of Clinical Oncology
Management of metastatic bone disease
article

Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases

Hiroaki Ogawa, Y. Nakajima, Kentaro Taguchi, Yuhi Suda, Keiko Nemoto Murofushi, Kei Ito
article en

Abstract

Re-irradiation SBRT achieved substantial pain relief with acceptable toxicity, warranting larger randomized trials against conventional radiotherapy.

Japanese Journal of Clinical Oncology
Tokyo Metropolitan Komagome Hospital (JP), Miyagi Prefectural Hospital Organization (JP), Komazawa University (JP)
Openalex Percentile: Top 24%
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.